Complexity Stage Model of the Medical Device Development Based on Economic Evaluation—MedDee

The development of a new product is essential for the progress and success of any company. The medical device market is very specific, which is challenging. Therefore, this paper assesses an economic model for medical device evaluation using the economic, health, technology regulatory, and present market knowledge to enable the cost–time conception for any applicant. The purpose of this study is to propose a comprehensive stage model of the medical device development to subsequently describe the financial expenditure of the entire development process. The identification of critical steps was based on the literature review, and analysis, and a comparison of the available medical device development stages and directives. Furthermore, a preliminary assessment of the medical device development steps and procedures on the basis of the interviews was performed. Six interviews were conducted with an average duration of one hour, focusing on areas: relevance and level of detail of the medical device development stages, involvement of economic methods, and applicability of the proposed model. Subsequently, the improvement and modification of the medical device investment process, based on respondents’ responses, were conducted. The authors have proposed the complexity model MedDee—Medical Devices Development by Economic Evaluation. This model is comprised of six phases: initiation, concept, design, production, final verification, and market disposition in which the economic methods are incorporated.

[1]  Elizabeth Murphy,et al.  A user-centred approach to requirements elicitation in medical device development: a case study from an industry perspective. , 2012, Applied ergonomics.

[2]  Jacky Akoka,et al.  An expert system for feasibility assessment of product development , 1994 .

[3]  Hendrik Koffijberg,et al.  Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature , 2017, PharmacoEconomics.

[4]  Amy Downing,et al.  High hospital research participation and improved colorectal cancer survival outcomes: a population-based study , 2016, Gut.

[5]  Maarten J. IJzerman,et al.  Integrating patients' views into health technology assessment: Analytic hierarchy process (AHP) as a method to elicit patient preferences , 2011, International Journal of Technology Assessment in Health Care.

[6]  Tomasz Korol Early warning models against bankruptcy risk for Central European and Latin American enterprises , 2013 .

[7]  John A. Vernon,et al.  Economic Evaluation and Cost-Effectiveness Thresholds , 2012, PharmacoEconomics.

[8]  Oliver Gassmann,et al.  Business Models for Frugal Innovation in Emerging Markets: The Case of the Medical Device and Laboratory Equipment Industry , 2017 .

[9]  Mats Geijer,et al.  Radiography on wheels arrives to nursing homes - an economic assessment of a new health care technology in southern Sweden. , 2016, Journal of evaluation in clinical practice.

[10]  İhsan Kaya,et al.  The prioritisation of provinces for public grants allocation by a decision-making methodology based on type-2 fuzzy sets , 2016 .

[11]  Luis R. Soenksen,et al.  Stage-gate process for life sciences and medical innovation investment , 2017 .

[12]  Blanka Klimova,et al.  The Business Process Model and Notation of Open Innovation: The Process of Developing Medical Instrument , 2019, Journal of Open Innovation: Technology, Market, and Complexity.

[13]  Munjae Lee,et al.  What Are the Features of Successful Medical Device Start-Ups? Evidence from KOREA , 2019, Sustainability.

[14]  J L Bootman,et al.  A review of cost-benefit and cost-effectiveness analyses of clinical pharmacy services. , 1988, Journal of pharmaceutical marketing & management.

[15]  Gyu Ha Ryu,et al.  Innovative Distribution Priorities for the Medical Devices Industry in the Fourth Industrial Revolution , 2018, International neurourology journal.

[16]  Lauren Aquino Shluzas,et al.  Stage-Gate Process for the Development of Medical Devices , 2009 .

[17]  C. Castañeda-Orjuela,et al.  Is There Something Else Beyond Cost-Effectiveness Analysis for Public Health Decision Making? , 2019, Value in health regional issues.

[18]  Karen Donohue,et al.  The decision to recall: A behavioral investigation in the medical device industry , 2018, Journal of Operations Management.

[19]  Karin Eklund Rt MSc Radiologic Technologist,et al.  Radiography on wheels arrives to nursing homes – an economic assessment of a new health care technology in southern Sweden , 2016 .

[20]  Ian Robinson,et al.  Benefits of and barriers to involving users in medical device technology development and evaluation , 2007, International Journal of Technology Assessment in Health Care.

[21]  D. Pieper,et al.  Methods of international health technology assessment agencies for economic evaluations- a comparative analysis , 2013, BMC Health Services Research.

[22]  Peter Wood,et al.  Cost‐effectiveness analysis at the development phase of a potential health technology: examples based on tissue engineering of bladder and urethra , 2007, Journal of tissue engineering and regenerative medicine.

[23]  Ilme Schlichting,et al.  Blue light-induced LOV domain dimerization enhances the affinity of Aureochrome 1a for its target DNA sequence , 2015, eLife.

[24]  J. Vernon,et al.  Economic Evaluation and Comparative-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation , 2009 .

[25]  Natcha Thawesaengskulthai,et al.  Medical Device Innovation Development Process , 2014 .

[26]  Susanne Hartz,et al.  Contribution of economic evaluation to decision making in early phases of product development: A methodological and empirical review , 2008, International Journal of Technology Assessment in Health Care.

[27]  Bonny Parkinson,et al.  Integrating Health Economics Into the Product Development Cycle , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[28]  Manuel L. Nunes,et al.  Incorporating sustainability in decision-making for medical device development , 2013 .

[29]  Rebecca L Ashby,et al.  VenUS IV (Venous leg Ulcer Study IV) - compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model. , 2014, Health technology assessment.

[30]  Ian Robinson,et al.  Developing medical device technologies from users' perspectives: A theoretical framework for involving users in the development process , 2009, International Journal of Technology Assessment in Health Care.

[31]  Richard Lilford,et al.  Early-stage valuation of medical devices: the role of developmental uncertainty. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[32]  Gül E. Okudan Kremer,et al.  Supporting medical device development: a standard product design process model , 2013 .

[33]  Hywel C. Williams,et al.  Better Decision Making for Evaluating New Medical Device Projects: A Real Options Approach: , 2008 .

[34]  Josep Samitier,et al.  Market challenges facing academic research in commercializing nano-enabled implantable devices for in-vivo biomedical analysis , 2012 .

[35]  František Freiberg,et al.  Evaluation of Investment in Modern Manufacturing Equipment Using Discrete Event Simulation , 2015 .

[36]  Jennifer L. Martin,et al.  The role of the user within the medical device design and development process: medical device manufacturers' perspectives , 2011, BMC Medical Informatics Decis. Mak..

[37]  Hui Li,et al.  Imbalance-oriented SVM methods for financial distress prediction: a comparative study among the new SB-SVM-ensemble method and traditional methods , 2014, J. Oper. Res. Soc..